Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
25.76
+2.67 (11.56%)
At close: Mar 9, 2026, 4:00 PM EDT
24.43
-1.33 (-5.16%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $356.89 million as of March 9, 2026. Its market cap has increased by 125.51% in one year.
Market Cap
356.89M
Enterprise Value
318.08M
1-Year Change
125.51%
Ranking
Category
Stock Price
$25.76
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $356.89M, an increase of 419.59%. That is a compound annual growth rate of 35.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 337.23M |
| Adlai Nortye | 328.78M |
| X4 Pharmaceuticals | 328.76M |
| Relmada Therapeutics | 326.33M |
| Rezolute | 323.04M |
| Avalo Therapeutics | 320.46M |
| Protara Therapeutics | 316.16M |
| Nautilus Biotechnology | 312.61M |